Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Papo

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.
Leukemia|May 28, 2025
Cluster analysis reveals the clinical spectrum of Erdheim-Chester diseaseMichelangelo Tesi, Francesco Pegoraro, Francesco Peyronel, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Journal of Internal Medicine|December 10, 2025
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter studyFederica Pallotti, Camille Mettler, Matthias Papo, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.
Leukemia|May 28, 2025
Cluster analysis reveals the clinical spectrum of Erdheim-Chester diseaseMichelangelo Tesi, Francesco Pegoraro, Francesco Peyronel, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Journal of Internal Medicine|December 10, 2025
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter studyFederica Pallotti, Camille Mettler, Matthias Papo, et al.
Pageof 4